Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Zenyaku Kogyo

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 5
Average round size
info
The average size of a deal this fund participated in
$8M
Portfolio companies 3
Rounds per year 0.07
Lead investments 1
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.40
Key employees Soon

Areas of investment

  • Biotechnology
  • Health Care
  • Therapeutics
  • Medical
  • Drug Delivery
Summary

Zenyaku Kogyo appeared to be the Corporate Investor, which was created in 1950. The venture was found in Asia in Japan. The main department of described Corporate Investor is located in the Tokyo.

Among the most successful fund investment fields, there are Medical, Health Care. For fund there is no match between the location of its establishment and the land of its numerous investments - United States. Among the most popular portfolio startups of the fund, we may highlight Theraclone Sciences. Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund.

The fund is constantly included in less than 2 deals per year. The common things for fund are deals in the range of 5 - 10 millions dollars. The important activity for fund was in 2013.

The standard case for the fund is to invest in rounds with 6 partakers. Despite the Zenyaku Kogyo, startups are often financed by MPM Capital, HealthCare Ventures, Canaan Partners. The meaningful sponsors for the fund in investment in the same round are Versant Ventures, ReproCELL, Nissei Capital. In the next rounds fund is usually obtained by Tohoku University Venture Partners, Silicon Valley Bank, ReproCELL.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Zenyaku Kogyo:
Typical Co-investors
Zenyaku Kogyo is more likely to invest in rounds together with the following funds:
There are no funds here. If we find new data, we will add it here.
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Zenyaku Kogyo:
There are no funds here. If we find new data, we will add it here.

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Aderans Japan, Tokyo
Ag Innovation Development Group -
Blackstone Life Sciences Cambridge, Massachusetts, United States
Broadband Capital Investments Florida, Miami, United States
Celanese Irving, Texas, United States
Foundation Venture Capital Group New Brunswick, New Jersey, United States
GITPx Central, Central Region, Singapore
Investion Amsterdam, Noord-Holland, The Netherlands
Jennison Associates New York, New York, United States
Joho Capital New York, New York, United States
Leede Jones Gable Alberta, Calgary, Canada
Ramot Israel, Tel Aviv, Tel Aviv District
RBC Canada, Ontario, Toronto
Rudin Ventures -
Seneca Creek Ventures Boston, Massachusetts, United States
The JumpFund Chattanooga, Tennessee, United States
TS Investment Dubai, United Arab Emirates
Valquest Partners Beirut, Beyrouth, Lebanon

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Theraclone Sciences

Biotechnology
Decision/Risk Analysis
Drug Delivery
Health Care
Medical
Therapeutics
$8M25 Mar 2013 Seattle, Washington, United States

Theraclone Sciences

Biotechnology
Decision/Risk Analysis
Drug Delivery
Health Care
Medical
Therapeutics
$10M08 Sep 2011 Seattle, Washington, United States

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Zenyaku Kogyo?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 5
Average round size 8M
Rounds per year 0.07
Peak activity year 2011
Lead investments 1
Follow on index 0.40
Group Appearance index 0.80

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

Theraclone Sciences

Biotechnology
Decision/Risk Analysis
Drug Delivery
Health Care
Medical
Therapeutics
$8M25 Mar 2013 Seattle, Washington, United States

Theraclone Sciences

Biotechnology
Decision/Risk Analysis
Drug Delivery
Health Care
Medical
Therapeutics
$10M08 Sep 2011 Seattle, Washington, United States
Crunchbase icon

Content report

The following text will be sent to our editors: